{"id":2280,"date":"2022-09-08T08:00:08","date_gmt":"2022-09-08T08:00:08","guid":{"rendered":"https:\/\/medxelerator.com\/?p=2280"},"modified":"2022-09-08T08:00:08","modified_gmt":"2022-09-08T08:00:08","slug":"almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment","status":"publish","type":"post","link":"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/","title":{"rendered":"Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment"},"content":{"rendered":"<p>Or Yehuda, Israel, 8\/9\/22 &#8212; MEDX Xelerator\u2019s latest initiative is the founding of NovaPulse Ltd., a bio-convergence company, which is addressing the multi-billion-dollar peripheral artery disease (PAD) market and helping the millions of claudication patients who suffer from pain and have trouble walking because of the insufficient blood supply in their legs.<\/p>\n<p>NovaPulse was formed by the MEDX Xelerator, with strategic input from Xelerator partner Boston Scientific, a global leader in PAD treatment, and with additional support from the Israeli Innovation Authority.<\/p>\n<p><strong>Today, Almeda Ventures (TASE: AMDA) became the newest seed investor in NovaPulse.<\/strong><\/p>\n<p>NovaPulse is the brainchild of the MEDX Xelerator team and Dr. Shaul Ozeri, and is based on unmet clinical needs identified through conversations with experts within the Boston Scientific peripheral interventions team.<\/p>\n<p>MEDX Xelerator CEO Shai Policker said, \u201cThe venture creation process continues to drive quality deal flow for our incubator. The creation of NovaPulse and the investment participation of Almeda Ventures, which brings valuable experience in this field, are the latest examples of this highly successful formula.\u201d<\/p>\n<p>Almeda Ventures CEO Dr. Irit Yaniv said, \u201cThe more we learned, the more we wanted to be a part of the unique MEDX Xelerator venture building process with strategic collaborators like Boston Scientific. \u00a0Among other benefits, it combines building solutions for real clinical and commercial unmet needs, like treating PAD, with strong strategic collaboration and creative financing solutions. We hope NovaPulse will be the first bio-convergence opportunity of many for us under this structure.\u201d<\/p>\n<p>NovaPulse CEO Dr. Shaul Ozeri said, \u201cPeople with peripheral arterial disease suffer terribly. We want these patients to <em>keep going,<\/em> painlessly and easily. \u00a0So, we are on a mission to develop a treatment that brings relief, improves today\u2019s standard of care, and significantly increases the quality of life for these patients.\u201d<\/p>\n<p><strong>About Almeda Ventures <\/strong>Almeda Ventures is a publicly traded R&amp;D Partnership, which invests in companies in the medical device, digital health and bio-convergence sectors. The fund\u2019s managers are Dr. Irit Yaniv, Amir Blatt and Tzahi Sultan. The fund has to date invested in nine companies in its areas of activity. Portfolio companies include: BioProtect, TailorMed, Lumen, Virility Medical, Belong, Augmedics, FlexDex, Sensi, and Nurami Medical.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>About MEDX Xelerator <\/strong><\/p>\n<p>MEDX Xelerator is a leading medical device and digital health-focused incubator operating under the auspices of the Israel Innovation Authority.\u00a0 Current partners and collaborators include:\u00a0 Boston Scientific, Sheba Medical Center, MEDX Venture Group, Consensus Business Group (CBG), West Pharmaceuticals and The Portland Trust. In cooperation with its partners and collaborators, MEDX Xelerator identifies and nurtures high impact medical ventures that fill major, unmet clinical needs with big markets, to benefit patients, physicians and investors alike. The incubator\u2019s management team works closely with the portfolio companies to consistently achieve outstanding clinical and business milestones in a capital efficient way.<\/p>\n<p>For more information, please visit <a href=\"https:\/\/medxelerator.com\/\">https:\/\/medxelerator.com\/<\/a>.<\/p>\n<p>&nbsp;<\/p>\n<p>International Media Contact:<\/p>\n<p>Marjie Hadad<\/p>\n<p>General Manager<\/p>\n<p>Must Have Communications<\/p>\n<p><a href=\"mailto:marjie@mhc-pr.com\">marjie@mhc-pr.com<\/a><\/p>\n<p>1-917-790-1178 or +972-54-536-5220<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Or Yehuda, Israel, 8\/9\/22 &#8212; MEDX Xelerator\u2019s latest initiative is the founding of NovaPulse Ltd., a bio-convergence company, which is addressing the multi-billion-dollar peripheral artery disease (PAD) market and helping the millions of claudication patients who suffer from pain and have trouble walking because of the insufficient blood supply in their legs. NovaPulse was formed [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment - MEDX Xelerator<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment - MEDX Xelerator\" \/>\n<meta property=\"og:description\" content=\"Or Yehuda, Israel, 8\/9\/22 &#8212; MEDX Xelerator\u2019s latest initiative is the founding of NovaPulse Ltd., a bio-convergence company, which is addressing the multi-billion-dollar peripheral artery disease (PAD) market and helping the millions of claudication patients who suffer from pain and have trouble walking because of the insufficient blood supply in their legs. NovaPulse was formed [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/\" \/>\n<meta property=\"og:site_name\" content=\"MEDX Xelerator\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-08T08:00:08+00:00\" \/>\n<meta name=\"author\" content=\"Soli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Soli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/\"},\"author\":{\"name\":\"Soli\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de\"},\"headline\":\"Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment\",\"datePublished\":\"2022-09-08T08:00:08+00:00\",\"dateModified\":\"2022-09-08T08:00:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/\"},\"wordCount\":515,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medxelerator.com\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/\",\"url\":\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/\",\"name\":\"Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment - MEDX Xelerator\",\"isPartOf\":{\"@id\":\"https:\/\/medxelerator.com\/#website\"},\"datePublished\":\"2022-09-08T08:00:08+00:00\",\"dateModified\":\"2022-09-08T08:00:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medxelerator.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medxelerator.com\/#website\",\"url\":\"https:\/\/medxelerator.com\/\",\"name\":\"MEDX Xelerator\",\"description\":\"Accelerating Science for Life\",\"publisher\":{\"@id\":\"https:\/\/medxelerator.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medxelerator.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medxelerator.com\/#organization\",\"name\":\"MEDX XELERATOR\",\"url\":\"https:\/\/medxelerator.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png\",\"contentUrl\":\"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png\",\"width\":819,\"height\":333,\"caption\":\"MEDX XELERATOR\"},\"image\":{\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de\",\"name\":\"Soli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medxelerator.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g\",\"caption\":\"Soli\"},\"url\":\"https:\/\/medxelerator.com\/author\/soli-dmedxelerator-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment - MEDX Xelerator","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/","og_locale":"en_US","og_type":"article","og_title":"Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment - MEDX Xelerator","og_description":"Or Yehuda, Israel, 8\/9\/22 &#8212; MEDX Xelerator\u2019s latest initiative is the founding of NovaPulse Ltd., a bio-convergence company, which is addressing the multi-billion-dollar peripheral artery disease (PAD) market and helping the millions of claudication patients who suffer from pain and have trouble walking because of the insufficient blood supply in their legs. NovaPulse was formed [&hellip;]","og_url":"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/","og_site_name":"MEDX Xelerator","article_published_time":"2022-09-08T08:00:08+00:00","author":"Soli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Soli","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/#article","isPartOf":{"@id":"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/"},"author":{"name":"Soli","@id":"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de"},"headline":"Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment","datePublished":"2022-09-08T08:00:08+00:00","dateModified":"2022-09-08T08:00:08+00:00","mainEntityOfPage":{"@id":"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/"},"wordCount":515,"commentCount":0,"publisher":{"@id":"https:\/\/medxelerator.com\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/","url":"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/","name":"Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment - MEDX Xelerator","isPartOf":{"@id":"https:\/\/medxelerator.com\/#website"},"datePublished":"2022-09-08T08:00:08+00:00","dateModified":"2022-09-08T08:00:08+00:00","breadcrumb":{"@id":"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medxelerator.com\/almeda-ventures-joins-medx-xelerator-and-israel-innovation-authority-in-vascular-medtech-startup-novapulse-investment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medxelerator.com\/"},{"@type":"ListItem","position":2,"name":"Almeda Ventures Joins MEDX Xelerator and Israel Innovation Authority in Vascular Medtech Startup NovaPulse Investment"}]},{"@type":"WebSite","@id":"https:\/\/medxelerator.com\/#website","url":"https:\/\/medxelerator.com\/","name":"MEDX Xelerator","description":"Accelerating Science for Life","publisher":{"@id":"https:\/\/medxelerator.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medxelerator.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medxelerator.com\/#organization","name":"MEDX XELERATOR","url":"https:\/\/medxelerator.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/","url":"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png","contentUrl":"https:\/\/medxelerator.com\/wp-content\/uploads\/2024\/01\/MEDX-LOGO.png","width":819,"height":333,"caption":"MEDX XELERATOR"},"image":{"@id":"https:\/\/medxelerator.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/medxelerator.com\/#\/schema\/person\/6aa968b04aab58d62b5cdf4743a360de","name":"Soli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medxelerator.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9f43cd27ac4be2a789af3eadaa07c484?s=96&d=mm&r=g","caption":"Soli"},"url":"https:\/\/medxelerator.com\/author\/soli-dmedxelerator-com\/"}]}},"_links":{"self":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts\/2280"}],"collection":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/comments?post=2280"}],"version-history":[{"count":3,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts\/2280\/revisions"}],"predecessor-version":[{"id":2283,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/posts\/2280\/revisions\/2283"}],"wp:attachment":[{"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/media?parent=2280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/categories?post=2280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medxelerator.com\/wp-json\/wp\/v2\/tags?post=2280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}